The portacaval shunt. Is it still indicated?

Area of Science:

• Gastroenterology and Hepatology
• Surgical Interventions for Portal Hypertension

Background:

• Variceal hemorrhage is a serious complication of portal hypertension.
• Recent advancements in treatment aim to improve patient outcomes and quality of life.
• The etiology of portal hypertension, particularly alcoholic cirrhosis, influences treatment choices.

Purpose of the Study:

• To evaluate the efficacy of recently introduced treatments for variceal hemorrhage.
• To compare newer modalities with established procedures like portacaval shunting.
• To determine optimal management strategies for variceal bleeding in portal hypertension.

Main Methods:

• Critical review of data on various treatment modalities.
• Inclusion of information on central shunts, selective shunting, non-shunt operations, hepatic transplantation, sclerotherapy, and pharmacologic manipulation.
• Presentation of a large series of side-to-side portacaval shunts.

Main Results:

• Some newer treatments are equivalent to portacaval shunting, while others are less appropriate.
• Side-to-side portacaval shunting demonstrated good results in a significant patient series.
• Treatment efficacy varies, particularly in patients with alcoholic cirrhosis-related portal hypertension.

Conclusions:

• The portacaval shunt remains a crucial intervention for managing hemorrhagic complications of portal hypertension.
• Clinicians should critically assess the basis for treatment decisions in variceal hemorrhage.
• Established methods like the portacaval shunt should be considered a mainstay in treatment protocols.